Product Details
Aromasin 25 mg Eksemestan kaplı Tablet In Pakistan
Aromasin 25mg contains exemestane, an aromatase inhibitor used as hormone therapy for certain types of breast cancer. It works by reducing the body's production of estrogen, which can help slow or prevent the growth of estrogen-dependent breast cancer cells.
Aromasin is primarily indicated for postmenopausal women with estrogen-receptor-positive early breast cancer following 2–3 years of tamoxifen therapy, and for certain cases of advanced breast cancer after progression following anti-estrogen therapy.
Benefits
- Contains 25mg exemestane.
- Aromatase inhibitor for hormone-sensitive breast cancer.
- Helps reduce estrogen production in postmenopausal women.
- Used as adjuvant hormonal therapy in selected early breast cancer cases.
- Used for certain advanced breast cancer cases after previous anti-estrogen treatment.
- Convenient once-daily oral tablet.
- Can be incorporated into a specialist-directed long-term cancer treatment plan.
Specifications
| Specification | Details |
|---|---|
| Brand | Aromasin |
| Active Ingredient | Exemestane |
| Strength | 25mg |
| Dosage Form | Coated / Film-Coated Tablet |
| Route | Oral |
| Drug Class | Aromatase Inhibitor |
| Therapeutic Category | Hormonal Anticancer Medicine |
| Tablet Description | Round, biconvex, off-white coated tablet |
| Tablet Marking | 7663 |
| Prescription Status | Prescription Medicine |
Each Aromasin coated tablet contains 25mg exemestane.
How To Use
Take Aromasin exactly as prescribed by your oncologist. The standard recommended dose for its approved breast-cancer indications is one 25mg tablet once daily after a meal. Swallow the tablet as directed and do not change the dose without medical advice.
For early breast cancer, treatment may continue until completion of the planned sequential hormonal-therapy course. For advanced breast cancer, treatment generally continues while the disease remains controlled and the medicine is tolerated, according to the oncologist's assessment.
Aromasin is not intended for use in premenopausal women unless ovarian function has been appropriately suppressed under specialist supervision. It should not be used during pregnancy or breastfeeding.
Why Choose Aromasin?
Aromasin provides targeted estrogen-lowering therapy through aromatase inhibition, making it an established treatment option for appropriately selected postmenopausal patients with hormone-sensitive breast cancer. Its once-daily 25mg tablet formulation also provides a convenient oral treatment option.
